RELIEF THERAPEUTICS N revenue for the last year amounted to 6.03 M CHF, the most of which — 6.03 M CHF — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 6.08 M CHF. The greatest contribution to the revenue figure was made by Europe (excluding Switzerland) — last year it brought RELIEF THERAPEUTICS N 2.89 M CHF, and the year before that — 2.41 M CHF.